Petros Syrris
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Protein-glutathionylation is traditionally viewed as a protective mechanism that shields cysteine-residues from irreversible oxidative damage. Its broader functional roles remain poorly understood, in part due to technical limitations in detecting this modification at scale. Here, we develop and leverage a new mass-spectrometry approach that preserves protein-glutathionylation, thereby revealing its widespread distribution across the proteome in cell models, worms, mice and human cardiac tissues. In all cases, we find that glutathionylation sites are enriched at both protein-protein interfaces and protein-active sites, and are highly conserved across species. We find that glutathionylation is dynamically redistributed in response to environmental challenges, thereby driving remodelling of cellular protein–protein interaction (PPI) networks, and access to protein active sites, with functional and phenotypic consequences. Finally, we show that glutathionylation accumulates on key cardiac-sarcomeric proteins in aged-mice and human cardiomyopathy biopsies, revealing its role in cardiovascular dysfunction. These findings reposition glutathionylation as a crucial regulatory PTM, akin to phosphorylation, that orchestrates adaptive cellular responses. This work redefines the role of glutathionylation, with broad implications for cell biology and disease.
Year:
2026
Background Desmoplakin (DSP) cardiomyopathy, caused by variants in the gene DSP , is a unique subtype of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathies. Specific diagnostic and disease staging criteria have yet to be developed for DSP cardiomyopathy. Objective Utilizing a large cohort of DSP cardiomyopathy patients and their genotype-positive family members, this study aims to develop diagnostic and disease staging criteria for DSP cardiomyopathy. Methods Patients from the DSP -ERADOS Network with complete rhythm monitoring, electrocardiogram and cardiac magnetic resonance imaging were enrolled. Diagnostic criteria were assessed in initially-presenting patients (probands) and their genotype-positive family members. Early disease criteria (with preserved left ventricular ejection fraction, LVEF) were integrated into standard LVEF-based classifications. Diagnostic and staging criteria were assessed by time-event analyses (major ventricular arrhythmia and heart failure events). Results A total of 605 patients with complete diagnostic testing were included (mean age 40 yr, 60% female, 40% probands). The most prevalent disease features in probands were premature ventricular contractions (PVCs) >500/24hr (66%), nonsustained ventricular tachycardia (NSVT, 29%), LV late gadolinium enhancement (LGE, 53%), and reduced LVEF (44%). The presence of any one of these features was 97% sensitive for diagnosis (along with a DSP pathogenic variant) and were therefore considered as diagnostic criteria. Using these criteria, 77% of genotype-positive family members were considered clinically affected. Isolated right ventricular (RV) involvement occurred in only 0.7%. The absence of diagnostic criteria identified a low-risk group (composite event rate 0.8%/year, p 50%, HR 2.7, p=0.04; intermediate: LVEF 41-49%, HR 3.7, p=0.009; advanced: LVEF <40% HR 10.3, p<0.001). LGE was mostly subepicardial (87%). Circumferential (ring-like) LGE was more frequent in intermediate or advanced vs early disease (66% vs 48%, p<0.001). Conclusion This study identifies genotype-specific diagnostic and disease staging criteria for DSP cardiomyopathy that improve identification of risk for both heart failure and sustained ventricular arrhythmias. This work highlights how gene-specific criteria may be used to refine diagnosis and staging for cardiomyopathy subtypes – a critical step as gene-targeted treatments move toward clinical trials.
Year:
2025
Snap frozen biopsies serve as a valuable clinical resource of archival material for disease research, as they enable a comprehensive array of downstream analyses to be performed, including extraction and sequencing of nucleic acids. Obtaining three-dimensional (3D) structural information prior to multi-omics is more challenging but could potentially allow for better characterisation of tissues and targeting of clinically relevant cells. Conventional histological techniques are limited in this regard due to their destructive nature and the reconstruction artifacts produced by sectioning, dehydration, and chemical processing. These limitations are particularly notable in soft tissues such as the heart. In this study, we assessed the feasibility of using synchrotron-based cryo-X-ray phase contrast imaging (cryo-X-PCI) of snap frozen myocardial biopsies and 3D structure tensor analysis of aggregated myocytes, followed by nucleic acid (DNA and RNA) extraction and analysis. We show that optimal sample preparation is the key driver for successful structural and nucleic acid preservation which is unaffected by the process of cryo-X-PCI. We propose that cryo-X-PCI has clinical value for 3D tissue analysis of cardiac and potentially non-cardiac soft tissue biopsies prior to nucleic acid investigation.
Year:
2024
Collaborators (33)
Arthur A M Wilde
University of Amsterdam
Nisha Gilotra
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Firat Duru
-
Andrew Cook
University College London
Kristina Haugaa
Professor
University of Oslo
A.s Amin
Cardiologist
Amsterdam University Medical Centers
Eric Smith
University of Michigan
Julia Cadrin-Tourigny
Clinical Assistant Professor
Université de Montréal
J. Peter van Tintelen
Head Department; clinical geneticist
Universitair Medisch Centrum Utrecht
Matthew Taylor
Professor
University of Colorado Anschutz Medical Campus
Lia Crotti
Director of the Cardiological Rehabilitation Unit, San Luca Hospital
IRCCS Istituto Auxologico Italiano
Victoria N. Parikh
Stanford University
Vishwanie Budhram-Mahadeo
Professor
University College London
Sing-Chien Yap
Researcher
Erasmus University Rotterdam
Michela Casella
Researcher
Università Politecnica delle Marche
Adam Helms
Assistant Professor
University of Michigan
James Ware
Professor
Imperial College London
Marco Merlo
University of Trieste
Konstantinos Thalassinos
University College London
Marina Cerrone
Research Assistant Professor of Medicine
NYU School of Medicine
Gianfranco Sinagra
University of Trieste
Barbara Bauce
Associate Professor
University of Padova
Hugh Calkins
Johns Hopkins University School of Medicine
Cynthia James
Associate Professor
Johns Hopkins University
cristina basso
Professore Ordinario di Anatomia Patologica
University of Padova
Kalliopi Pilichou
Associate Professor
University of Padua
Ardan M. Saguner
-
Luisa Mestroni
Professor of Medicine
University of Colorado Anschutz Medical Campus
Juan Gimeno Blanes
Associate Professor
Universidad de Murcia
Kan Yan Chloe Li
Postgraduate Teaching Assistant
University College London
Marco Schiavone
Clinical Scientist
Centro Cardiologico Monzino
Giovanni Peretto
Vita-Salute San Raffaele University
Perry Elliott
University College London
Make your next move.
Prepare your application
Review drafts before you send them.